Magnetar Financial’s Intersect ENT, Inc XENT Stock Holding History

Magnetar Financial’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,537,735	Closed	-$71.1M	–	2002
2022 Q1	$71.1M	Sell	2,537,735 -31,317	-1%	-$858K	0.76%	25
2021 Q4	$70.2M	Buy	2,569,052 +11,289	+0.4%	+$306K	0.7%	24
2021 Q3	$69.6M	Buy	+2,557,763	New	+$63.2M	0.71%	29
2020 Q2	–	Sell	-13,605	Closed	-$161K	–	611
2020 Q1	$161K	Buy	+13,605	New	+$302K	﹤0.01%	414

Magnetar Financial's XENT Position: Q2 2022 in Review

Magnetar Financial sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 2,537,735 shares — an estimated $71.1M sold.

Magnetar Financial first reported a position in XENT in Q1 2020 and held it in 4 quarters. The position peaked at $71.1M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

Magnetar Financial reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
Magnetar Financial sold 2,537,735 Intersect ENT, Inc shares in Q2 2022, an estimated $71.1M.
Magnetar Financial first reported a position in Intersect ENT, Inc in Q1 2020 and held it in 4 quarters.
Magnetar Financial's Intersect ENT, Inc position peaked at $71.1M in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Magnetar Financial's 13F filing for Q2 2022, filed 15 Aug 2022.